Use this template to create your Risk Based Monitoring guideline. Make sure you review this in conjunction with the Risk Based Monitoring in Practice presentation for the best possible result.
After reviewing the FDA regulations on Risk Based Monitoring, review the details on how to put the principles into action! We include two reference documents to help you get started... and to make it a success.
Presentation delivered by Lori A. Tierney, BSN, Director, Site Management Operations, Allergan, Inc. at the marcus evans Evolution Summit Fall 2019 in San Diego CA.
Niki Kutac, Director Product Management, delivered this presentation at the ACRP 2014 Conference where it was rated the #1 Session of the Event. Learn how to implement gamification to produce the desired end result.
Risk-based Monitoring Strategies for Improved Clinical Trial PerformanceCognizant
To address draft regulatory guidance for risk-based clinical trial monitoring, sponsors should consider strategies that utilize social, mobile, analytics and cloud technologies to create responsive methodologies that satisfy both the spirit and the letter of these new guidelines.
The FDA Guidance of a Risk-Based Approach to Monitoring as Viewed By CDMwww.datatrak.com
Historical Perspectives in CDM
Overview of the Draft Guidance
A Risked-Based Approach
Challenges to a Risk-Based Approach
Supporting a Risked-Based Approach
After reviewing the FDA regulations on Risk Based Monitoring, review the details on how to put the principles into action! We include two reference documents to help you get started... and to make it a success.
Presentation delivered by Lori A. Tierney, BSN, Director, Site Management Operations, Allergan, Inc. at the marcus evans Evolution Summit Fall 2019 in San Diego CA.
Niki Kutac, Director Product Management, delivered this presentation at the ACRP 2014 Conference where it was rated the #1 Session of the Event. Learn how to implement gamification to produce the desired end result.
Risk-based Monitoring Strategies for Improved Clinical Trial PerformanceCognizant
To address draft regulatory guidance for risk-based clinical trial monitoring, sponsors should consider strategies that utilize social, mobile, analytics and cloud technologies to create responsive methodologies that satisfy both the spirit and the letter of these new guidelines.
The FDA Guidance of a Risk-Based Approach to Monitoring as Viewed By CDMwww.datatrak.com
Historical Perspectives in CDM
Overview of the Draft Guidance
A Risked-Based Approach
Challenges to a Risk-Based Approach
Supporting a Risked-Based Approach
How To Optimize Your EDC Solution For Risk Based Monitoringwww.datatrak.com
This presentation presents best training practices to leverage EDC technology and risk-based monitoring to effectively and efficiently monitor clinical research.
Our focus is on the practical process of preparing your team to optimize the tools made available through an EDC solution.
This presentation is applicable to CRA’s, clinical project managers, clinical data managers, regulatory compliance professionals, and those involved in the design and implementation of risked-based monitoring plans.
Risk based monitoring presentation into what Risk Based Monitoring (RBM) is all about. The value of getting it right, and the risks of getting it wrong. We look at the Triumph Research Intelligence (TRI) approach to RBM, and the TRI solution to RBM. An insight into the Future of Visual OPRA is given.
With the regulators moving forward with guidance on risk based monitoring, and the industry trend of
adopting this approach, this presentation will aim to demonstrate how the combination of CTMS, EDC
and analytics can be used to identify and manage site risk profiles. The presentation will draw from the
work completed by the MCC members and show how the Site Scoring tools for Site Selection and Study
Conduct can be used to generate a risk profile dashboard based on data from CTMS and EDC. The
presentation will further explore how data captured in CTMS and EDC can be used to update the risk
profile of the site during the course of the study, allowing the study team to proactively manage risk.
Leverage Your EDC Solution to Mitigate Risk in Clinical Researchwww.datatrak.com
Every clinical trial is built upon a study protocol - the cornerstone of any trial. A well-defined and written study protocol provides the blueprint for the study, defining its purpose and goals. Studies have become more complex, creating more complicated study design, which can lead to making adherence more challenging for the study team and participants. The potential risk that some aspect of the study could be done incorrectly or not comply is inherent in all studies, but particularly present in complex research.
In order to help mitigate risk, advances in technology and the tools available today provide ways for us to mitigate some of the risk introduced in our clinical trials. While the study protocol is a cornerstone for the clinical trial, electronic data capture (EDC) applications have evolved in the broadest sense into technology solutions that provide us with a variety of tools to help mitigate risk.
CDISC & Risk Based Monitoring to Compress Clinical Trial DurationClinical Data Inc .
Technology adoption in the clinical trial space has lagged other industries resulting in high cost / risk of new drug development and ongoing safety concerns of clinical trials.
The focus of this presentation is to educate bio-pharma companies, data managers and CROs on technological advances in the clinical trial space.
CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.Quality Management in clinical operations are Centralized Monitoring, Study Quality Metrics and CRO Oversight.
In the course of any clinical trial, there are risks associated with specific activities and tasks. This webinar will highlight some of these key risk areas and provide guidance on combining technology with best practices to help mitigate risks.
Sandra Maddock, RN, BSN, CCRA and President of IMARC Research, Inc. presents on Applying FDA’s Risk-Based Approach in an audio conference on September 11, 2012.
This Presentation is about why CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.
Topics covered:
1.Importance of CRO/Vendor oversight in clinical trial management.
2. Identify the ways to integrate a risk-based approaches to CRO/Vendor oversight.
3. Developing a CRO/Vendor oversight plan with appropriate KPIs/metrics to be measured.
4. Use of tools and technology for accurate and timely reporting.
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...WorldCongress
This Summit offers pharmaceutical and medical device delegates concrete examples of how to build a framework and methodology for a risk-based monitoring (RBM) program that is part of an overall risk management approach to study planning and oversight. One of the biggest challenges of implementation is overcoming resistance to change as no organization wants to be the first. For that reason, Summit faculty share change management strategies for people, processes, and technology that led to the effective implementation of their RBM programs. The Site’s perspective, assessing readiness for change and providing support during the change process must not be overlooked. Strategies to partner with Sites to achieve stronger connectivity will also be discussed.
The Risk-Based Monitoring (RBM) discussion is moving away from one focused on changing monitoring methods and reducing source document verification (SDV) to 'intelligent monitoring.' Learn why here!
A project with the aim to standardize an RBM approach in clinical trials. It unites four companies and academic organizations, focuses on the evaluation and optimization of Risk-based Monitoring (RbM). For this purpose, PUEKS will use data available from past clinical studies to select substantiated key risk indicators (KRIs). Subsequently, the obtained data-driven KRIs will be tested in an ongoing trial. A comparative evaluation with historical data from past studies will be additionally performed to evaluate the power of the selected KRIs in terms of cost savings, enhanced quality, and risk mitigation. The project is aimed at delivering a robust RbM tool as well as an optimized procedure for the successful implementation of RbM.
This project (HA project no. 448/14-38) is funded in the framework of Hessen ModellProjekte, financed with funds of LOEWE – Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz, Förderlinie 3: KMU-Verbundvorhaben (State Offensive for the Development of Scientific and Economic Excellence).
Developing and maintaining strong relationships between the Sponsor and the selected CRO can make or break a clinical study. In this webinar, two experts with experience managing clinical programs from both a CRO and a Sponsor perspective provide tips and strategies for optimizing these relationships using real world examples.
This Risk Based Monitoring - Impact on Sites overview presentation, on targeted topics, was delivered to the ACRP Raleigh - Durham Chapter's Annual Conference in 2013.
Integrating Clinical Operations and Clinical Data Management Through EDCwww.datatrak.com
When electronic data capture was first introduced there was a great deal of discussion surrounding how the technology would alter the roles of those in clinical operations and clinical data management. Through the review of a case study, we will explore how EDC is used as a tool to more tightly integrate clinical operational staffs with those in clinical data management resulting in a more streamlined process from study initiation to database lock.
Effective risk management needs effective risk identification, assessment, planning, tracking and controlling in Clinical Trials. Considering the importance of risk management in efficient management of clinical trials, this webinar by DDismart will provide more insight on Clinical RBM.
How To Optimize Your EDC Solution For Risk Based Monitoringwww.datatrak.com
This presentation presents best training practices to leverage EDC technology and risk-based monitoring to effectively and efficiently monitor clinical research.
Our focus is on the practical process of preparing your team to optimize the tools made available through an EDC solution.
This presentation is applicable to CRA’s, clinical project managers, clinical data managers, regulatory compliance professionals, and those involved in the design and implementation of risked-based monitoring plans.
Risk based monitoring presentation into what Risk Based Monitoring (RBM) is all about. The value of getting it right, and the risks of getting it wrong. We look at the Triumph Research Intelligence (TRI) approach to RBM, and the TRI solution to RBM. An insight into the Future of Visual OPRA is given.
With the regulators moving forward with guidance on risk based monitoring, and the industry trend of
adopting this approach, this presentation will aim to demonstrate how the combination of CTMS, EDC
and analytics can be used to identify and manage site risk profiles. The presentation will draw from the
work completed by the MCC members and show how the Site Scoring tools for Site Selection and Study
Conduct can be used to generate a risk profile dashboard based on data from CTMS and EDC. The
presentation will further explore how data captured in CTMS and EDC can be used to update the risk
profile of the site during the course of the study, allowing the study team to proactively manage risk.
Leverage Your EDC Solution to Mitigate Risk in Clinical Researchwww.datatrak.com
Every clinical trial is built upon a study protocol - the cornerstone of any trial. A well-defined and written study protocol provides the blueprint for the study, defining its purpose and goals. Studies have become more complex, creating more complicated study design, which can lead to making adherence more challenging for the study team and participants. The potential risk that some aspect of the study could be done incorrectly or not comply is inherent in all studies, but particularly present in complex research.
In order to help mitigate risk, advances in technology and the tools available today provide ways for us to mitigate some of the risk introduced in our clinical trials. While the study protocol is a cornerstone for the clinical trial, electronic data capture (EDC) applications have evolved in the broadest sense into technology solutions that provide us with a variety of tools to help mitigate risk.
CDISC & Risk Based Monitoring to Compress Clinical Trial DurationClinical Data Inc .
Technology adoption in the clinical trial space has lagged other industries resulting in high cost / risk of new drug development and ongoing safety concerns of clinical trials.
The focus of this presentation is to educate bio-pharma companies, data managers and CROs on technological advances in the clinical trial space.
CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.Quality Management in clinical operations are Centralized Monitoring, Study Quality Metrics and CRO Oversight.
In the course of any clinical trial, there are risks associated with specific activities and tasks. This webinar will highlight some of these key risk areas and provide guidance on combining technology with best practices to help mitigate risks.
Sandra Maddock, RN, BSN, CCRA and President of IMARC Research, Inc. presents on Applying FDA’s Risk-Based Approach in an audio conference on September 11, 2012.
This Presentation is about why CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.
Topics covered:
1.Importance of CRO/Vendor oversight in clinical trial management.
2. Identify the ways to integrate a risk-based approaches to CRO/Vendor oversight.
3. Developing a CRO/Vendor oversight plan with appropriate KPIs/metrics to be measured.
4. Use of tools and technology for accurate and timely reporting.
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...WorldCongress
This Summit offers pharmaceutical and medical device delegates concrete examples of how to build a framework and methodology for a risk-based monitoring (RBM) program that is part of an overall risk management approach to study planning and oversight. One of the biggest challenges of implementation is overcoming resistance to change as no organization wants to be the first. For that reason, Summit faculty share change management strategies for people, processes, and technology that led to the effective implementation of their RBM programs. The Site’s perspective, assessing readiness for change and providing support during the change process must not be overlooked. Strategies to partner with Sites to achieve stronger connectivity will also be discussed.
The Risk-Based Monitoring (RBM) discussion is moving away from one focused on changing monitoring methods and reducing source document verification (SDV) to 'intelligent monitoring.' Learn why here!
A project with the aim to standardize an RBM approach in clinical trials. It unites four companies and academic organizations, focuses on the evaluation and optimization of Risk-based Monitoring (RbM). For this purpose, PUEKS will use data available from past clinical studies to select substantiated key risk indicators (KRIs). Subsequently, the obtained data-driven KRIs will be tested in an ongoing trial. A comparative evaluation with historical data from past studies will be additionally performed to evaluate the power of the selected KRIs in terms of cost savings, enhanced quality, and risk mitigation. The project is aimed at delivering a robust RbM tool as well as an optimized procedure for the successful implementation of RbM.
This project (HA project no. 448/14-38) is funded in the framework of Hessen ModellProjekte, financed with funds of LOEWE – Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz, Förderlinie 3: KMU-Verbundvorhaben (State Offensive for the Development of Scientific and Economic Excellence).
Developing and maintaining strong relationships between the Sponsor and the selected CRO can make or break a clinical study. In this webinar, two experts with experience managing clinical programs from both a CRO and a Sponsor perspective provide tips and strategies for optimizing these relationships using real world examples.
This Risk Based Monitoring - Impact on Sites overview presentation, on targeted topics, was delivered to the ACRP Raleigh - Durham Chapter's Annual Conference in 2013.
Integrating Clinical Operations and Clinical Data Management Through EDCwww.datatrak.com
When electronic data capture was first introduced there was a great deal of discussion surrounding how the technology would alter the roles of those in clinical operations and clinical data management. Through the review of a case study, we will explore how EDC is used as a tool to more tightly integrate clinical operational staffs with those in clinical data management resulting in a more streamlined process from study initiation to database lock.
Effective risk management needs effective risk identification, assessment, planning, tracking and controlling in Clinical Trials. Considering the importance of risk management in efficient management of clinical trials, this webinar by DDismart will provide more insight on Clinical RBM.
Assessment – SITXOHS004BStudent name ____________________________.docxfredharris32
Assessment – SITXOHS004BStudent name: ____________________________
What you have to do
There are a total of three (3) parts to complete, as follows:
Part A – consists of tasks requiring an extended response answer.
Part B – consists of a task requiring an extended response answer.
Part C – consists of short answers.
Securely attach your answers on separate sheets that clearly identify the question to which you are responding and number the pages in sequence. At the end of each answer, allow adequate space (at least 6-8 lines), for the teacher’s comments and feedback.
You will be assessed on how well you interpret each task request and how you structure each according to layout, sequencing and by providing all relevant and applicable details for each task.
This is an ungraded unit. Your result is based on the evidence you provide to meet the criteria for competence as specified in the unit of competency and grading criteria. You will receive a result of Achieved Competency (AC) or Not yet Competent (NC).
Information on how to submit your assignment is located on the OTEN website under your OLS log-in.
Tasks
Part A: Develop a WHS Program or Procedure
Task
In this Unit of Competency we learnt that it is common practice for organisations to adopt the “Six Step Approach” to develop and implement a Work health and Safety Management System (WHSMS).
As you discovered, an organisation’s WHS Policy forms the “corner stone” of the WHSMS and clearly states the organisation’s commitment to WHS and identifies the initiatives that will be taken to ensure a safe work environment is provided to all persons working in, serviced by, or visiting the workplace.
For part A of this Assessment you are required to write one (1) WHS Program or Procedure that aims to fulfil the goals set by an Organisation’s WHS Policy.
To successfully complete this task you must:
1. Read the following example WHS Policy for “Big Corp Travel”.
2. Select one (1) of the WHS programs or procedures listed in the WHS Policy for this tourism company and prepare (write) a detailed program or procedure that can be included in the Organisation’s WHS Programs manual.
3. Your WHS Program/Procedure must contain and address the following paragraph headings:
· WHS Program/Procedure title (name).
· Purpose and objectives (what does the program/procedure aim to achieve?)
· Scope (who does this program/procedure apply to? Departments and personnel)
· Program/Procedure (outline the steps in the program – what, where, how)
· Implementation Strategies (how will the program be implemented and communicated to staff?)
· Monitoring and Evaluation (how will the program be monitored and evaluated?)
· Review (when will this program be reviewed to ensure that it remains current and relevant and who will conduct this revision?)
Example WHS Policy
Commitment statement
The health and safety of all persons employed within Big Corp Travel, its customers and those visiting the workplace is cons ...
We all understand why improvement and a focus on excellence are important, so what we need is a method to use to help with our improvement efforts.FOCUS-PDCA is an improvement methodology that many organizations use to guide their improvement efforts. It’s simply a formalized process for improvement.
1)The Steps for Data to ImplimentationPlanning for ChangeChange.pdfssuserd6ce341
1)The Steps for Data to Implimentation:
Planning for Change
Change is complex and dynamic. It involves moving or transforming from something familiar to
something new. Change can be broad, affecting multiple practices or aspects of the program, or it
might be narrow, affecting fewer practices. Regardless of the scale, change is a dynamic active
and on-going process, rather than a single event.
There are many reasons for programs or agencies to engage in a change process. Some of these
may include:
• A newly defined vision or direction
• A crisis
• A new mandate
• Data that supports a change is needed
It is important that program and agency leaders first examine the current organizational and
political climate to assess readiness to both begin and sustain implementation and scaling up (or
expansion) of new practices or an innovation. It is important to recognize that, planning and
engaging in the implementation of any new innovation, evidence-based practice, or cluster of
practices takes time, energy and resources. The change process can be understood and organized
using defined steps and subsequent activities that are needed to move a concept into reality.
These steps and activities are outlined in the following document, \"A Guide to the
Implementation Process: Stages, Steps and Activities\".
Stage 1: Exploration
The State Leadership Team (SLT) should include cross- sector representation of agencies and
programs impacted by the proposed initiative. The composition, vision and mission of this initial
team may change over time as they go through the stages and steps.
The SLT ensures that the perspectives of key stakeholders from every level of the service system
are included as a part of a needs assessment of the current service delivery system. All available
data describing current challenges and need for change should be gathered and shared with
stakeholders. Stakeholders help build a common understanding of the current status and the
desired changes in practices and outcomes.During the exploration stage, an important
consideration for the State Leadership Team is whether they can commit to a multi-year
implementation process.
example of Exploration
• A State Leadership Team has been established to oversee the initiative.
• A stakeholder group has explored the need for change and the fit of potential new practices or
innovation.
• An innovation or set of practices was selected which addresses the need and is likely to result
in desired example.
• The service system and current practices were analyzed to determine necessary changes in
infrastructure, and training, technical assistance and coaching.
• The decision was made to proceed with the implementation initiative and move into
installation.
• Necessary agency or cross agency leadership has committed to supporting the implementation
of selected practices over multiple years.
Stage 2: Installation
The goal of the installation stage is to build system capacity which will support the
implemen.
Reflective Journal 9 Benefits and Dangers of Social NetworksW.docxcarlt3
Reflective Journal 9: Benefits and Dangers of Social Networks
Write a 3/4 to 1 page journal entry (300 to 500 words) in which you:
1. Discuss two or three (2-3) benefits you or others have experienced with social networks.
2. Discuss one or two (1-2) dangers you or others have experienced with social networks.
3. Complete the page requirement.
4. Write with clarity, following mechanics and formatting requirements.
The specific course learning outcome(s) associated with this assignment are:
· Apply critical thinking skills to the analysis of issues involving mass media and society.
· Analyze ways in which different types of media content reflect and / or influence society’s attitudes and behaviors.
· Analyze various issues affecting the media business.
· Evaluate the effects of new forms of media (e.g., online services) on social interactions.
· Write clearly and concisely about media and society using proper writing mechanics.
Grading for this assignment will be based on answer quality, and language and writing skills, using the following rubric.
Click here to view the grading rubric.
Data Analysis and Reporting
Chapter 15
Data ManagementIncludes coding, cleaning, and organizing data into a usable format (preparing for analysis)
Coding – assigning labels so data can be read and understood by a computer (e.g., 1=yes, 2=no)
Cleaning – values are valid and consistent (e.g., 1=true, 2=false, there should be no 3s); Also, need to deal with missing data
Data AnalysisBegins with being able to identify the variables
Variables – a characteristic or attribute that can be measured or observed (Creswell, 2002)
Types of variables: independent (controlled or cause or exert some influence) and dependent (are outcome variables that are being studied)
Also, the level(s) of data collected are importantNominal OrdinalNumerical (interval and ratio)
Data Analysis (cont.)Descriptive statistics – used to organize, summarize and describe characteristics
Inferential statistics – concerned with relationships and causality to make generalizations about a population based on a sample
AnalysesUnivariate (1 variable) Bivariate (2 variables)Multivariate (More than 2 variables)
Examples of Evaluation Questions Answered
Univariate Data AnalysesOne variable at a time
Summary counts (frequency distributions)
Measures of central tendency – e.g., mean, median, and mode
Measures of spread or variation – e.g., range, standard deviation, variance
Bivariate AnalysesCan be non-statistical comparisonsExample of non-statistical comparisons (eyeballing the data)
Male Female
Yes 35 62
No 50 46
Bivariate Analyses (cont.)HypothesesNull: statement of no significant difference Type I error – rejecting the null hypothesis when it is trueType II error – failing to reject the null hypothesis when it is not true (accepting a false null hypothesis)Level of significance (alpha level) – probability of making a type I error; e.g., p<.01A.
Defining a Central Monitoring Capability: Sharing the Experience of TransCele...www.datatrak.com
Central monitoring, on-site monitoring, and off-site monitoring provide an integrated approach to clinical trial quality management. TransCelerate distinguishes central monitoring from other types of central data review activities and puts it in the context of an overall monitoring strategy. Any organization seeking to implement central monitoring will need people with the right skills, technology options that support a holistic review of study-related information, and adaptable processes. There are different approaches actively being used to implement central monitoring. This article provides a description of how companies are deploying central monitoring, as well as samples of the workflows that illustrate how some have implemented it. The desired outcomes include earlier, more predictive detection of quality issues. This paper describes the initial implementation steps designed to learn what organizational capabilities are necessary.
Technology Considerations to Enable the Risk-Based Monitoring Methodologywww.datatrak.com
TransCelerate BioPharma Inc developed a methodology based on the notion that shifting monitoring processes from an excessive concentration on source data verification to comprehensive risk-driven monitoring will increase efficiencies and enhance patient
safety and data integrity while maintaining adherence to good clinical practice regulations. This philosophical shift in monitoring processes employs the addition of centralized and off-site mechanisms to monitor important trial parameters holistically, and it uses adaptive on-site monitoring to further support site processes, subject safety, and data quality. The main tenet is to use available data to monitor, assess, and mitigate the overall risk associated with clinical trials. Having the right technology is critical to collect and aggregate data, provide analytical capabilities, and track issues to demonstrate that a thorough quality management framework is in place. This paper lays out the high-level considerations when designing and building an integrated technology solution that will aid in scaling the methodology across an organization’s portfolio.
View this recorded webinar to hear an overview of the Guidance Document on Electronic Source Data in Clinical Investigations and its practical implementation.
eSource: A Clinical Data Manager's Tale of Three Studieswww.datatrak.com
‘eSource: A Clinical Data Manager’s Tale of Three Studies’ highlights the challenges and benefits of eSource studies, and a look to the potential future. With the continuing adoption of eClinical solutions in clinical research, the need to understand, address, and utilize the time and cost savings benefits of eSource will grow increasingly important.
Utilizing a Unified Platform to Bridge Geographical and Departmental Gaps Whi...www.datatrak.com
Presentation discusses:
The Drug Development Process
The Drug Development Paradox
Regulations and Guidelines
Standards - CDISC
Leveraging Technology
Resource Management
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualityInflectra
In this insightful webinar, Inflectra explores how artificial intelligence (AI) is transforming software development and testing. Discover how AI-powered tools are revolutionizing every stage of the software development lifecycle (SDLC), from design and prototyping to testing, deployment, and monitoring.
Learn about:
• The Future of Testing: How AI is shifting testing towards verification, analysis, and higher-level skills, while reducing repetitive tasks.
• Test Automation: How AI-powered test case generation, optimization, and self-healing tests are making testing more efficient and effective.
• Visual Testing: Explore the emerging capabilities of AI in visual testing and how it's set to revolutionize UI verification.
• Inflectra's AI Solutions: See demonstrations of Inflectra's cutting-edge AI tools like the ChatGPT plugin and Azure Open AI platform, designed to streamline your testing process.
Whether you're a developer, tester, or QA professional, this webinar will give you valuable insights into how AI is shaping the future of software delivery.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
PHP Frameworks: I want to break free (IPC Berlin 2024)Ralf Eggert
In this presentation, we examine the challenges and limitations of relying too heavily on PHP frameworks in web development. We discuss the history of PHP and its frameworks to understand how this dependence has evolved. The focus will be on providing concrete tips and strategies to reduce reliance on these frameworks, based on real-world examples and practical considerations. The goal is to equip developers with the skills and knowledge to create more flexible and future-proof web applications. We'll explore the importance of maintaining autonomy in a rapidly changing tech landscape and how to make informed decisions in PHP development.
This talk is aimed at encouraging a more independent approach to using PHP frameworks, moving towards a more flexible and future-proof approach to PHP development.
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
Key Trends Shaping the Future of Infrastructure.pdfCheryl Hung
Keynote at DIGIT West Expo, Glasgow on 29 May 2024.
Cheryl Hung, ochery.com
Sr Director, Infrastructure Ecosystem, Arm.
The key trends across hardware, cloud and open-source; exploring how these areas are likely to mature and develop over the short and long-term, and then considering how organisations can position themselves to adapt and thrive.
Connector Corner: Automate dynamic content and events by pushing a buttonDianaGray10
Here is something new! In our next Connector Corner webinar, we will demonstrate how you can use a single workflow to:
Create a campaign using Mailchimp with merge tags/fields
Send an interactive Slack channel message (using buttons)
Have the message received by managers and peers along with a test email for review
But there’s more:
In a second workflow supporting the same use case, you’ll see:
Your campaign sent to target colleagues for approval
If the “Approve” button is clicked, a Jira/Zendesk ticket is created for the marketing design team
But—if the “Reject” button is pushed, colleagues will be alerted via Slack message
Join us to learn more about this new, human-in-the-loop capability, brought to you by Integration Service connectors.
And...
Speakers:
Akshay Agnihotri, Product Manager
Charlie Greenberg, Host
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
Leading Change strategies and insights for effective change management pdf 1.pdf
Monitoring Plan Template
1. Monitoring Plan Template
Study Protocol:
Stage/Phase of Study:
Introduction:
Brief description of the study landscape – geography of the sites, anticipated reach of the population,
potential challenges in terms of enrollment and compliance by both study participants and sites.
Description of Monitoring Approaches:
Include in this section a description of the monitoring methods to be employed especially noting how the
critical elements/data points/end points will be collected. Note too and risks involved and how these risks
might be mitigated (at a high level). Also include the timing and frequency of the various approaches you
are planning and how changes will be made and communicated through the study team.
In this section also include what the threshold are for action or those specific trigger points that might
require a site to be monitoring on a more frequent basis.
Also include definitions for deviations and how they should be reported and recorded.
Communication Plan:
Describe how reports and monitoring results will be communicated throughout the team. Identify/Define
specific standard reports and how and when they will be generated and then communicated.
Also include an escalation process of communication should the need arise or unforeseen challenges
emerge during the course of the study.
Management of Noncompliance:
Describe the process for addressing challenges of noncompliance or the resolution of significant issues
that have not yet been resolved. Again build upon the communication escalation process to make sure
that there is an escalation process in place should it be necessary.
As part of the process, in this section you should also describe a procedure to conduct a root cause
analysis and how the issue will not resurface later in the study.
Quality Monitoring Process/Plan:
In this section describe the specific training and qualifications needed of all study team participants from
the sponsor’s perspective through to each site perspective.
Planned audits of monitoring across several levels should be defined as well as a description of the
process in case there is a need for an unplanned or for cause audit.
Also included in this section should be the plan for co-monitoring trips or oversight to ensure consistency
of monitoring and compliance to documented monitoring processes and procedures.
Amendments